Metabolic Engineering of Escherichia coli for De Novo Biosynthesis of the Platform Chemical Pelletierine

被引:0
作者
Li, Wei [1 ]
Zhao, Peng [2 ]
Li, Ying [3 ]
Wu, Shimin [1 ]
Tian, Pingfang [1 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China
[2] Beijing Univ Agr, Coll Biosci & Resources Environm, Beijing 102206, Peoples R China
[3] Beijing Union Univ, Coll Biochem Engn, Beijing 100023, Peoples R China
基金
中国国家自然科学基金;
关键词
huperzine A; pelletierine; Alzheimer'sdisease; Escherichia coli; metabolic engineering; CRISPRI; ACID;
D O I
10.1021/acssuschemeng.4c05975
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pelletierine is a versatile plant alkaloid having a C5N-C3 structure from which numerous chemicals can be derived. One notable derivative is huperzine A (HupA) which may alleviate the symptoms of Alzheimer's disease. Currently, industrial production of pelletierine relies primarily on chemical synthesis and plant extraction. However, chemical synthesis leads to analogues that complicate product separation, and plant extraction is constrained by limited resources. Herein, we report that pelletierine can be produced by recombinant Escherichia coli in which the engineered pelletierine biosynthesis pathway comprises four modules involving seven key genes native to E. coli, three genes from other bacteria, and three genes from plants. To overproduce pelletierine, the intrinsic l-lysine biosynthesis pathway in E. coli was simplified, and a clustered regularly interspaced short palindromic repeats (CRISPR) interference (CRISPRi) system was engineered to minimize the byproducts. Moreover, the transporter MatC was overexpressed to enhance the intracellular concentration of 3-oxoglutaryl ketide, which is another precursor of pelletierine. Based on the aforementioned manipulations, the resulting recombinant E. coli harboring the pelletierine biosynthesis pathway and CRISPRi system produced 3.40 and 8.23 mg/L pelletierine in a shake-flask and a 5 L bioreactor, respectively. This is the first report of microbial production of pelletierine, which represents a sustainable route to produce the precursor of HupA and beyond.
引用
收藏
页码:778 / 790
页数:13
相关论文
共 54 条
[1]  
[Anonymous], 2022, World Alzheimer Report 2022
[2]   Codon optimality-mediated mRNA degradation: Linking translational elongation to mRNA stability [J].
Bae, Haneui ;
Coller, Jeff .
MOLECULAR CELL, 2022, 82 (08) :1467-1476
[3]   Tropinone synthesis via an atypical polyketide synthase and P450-mediated cyclization [J].
Bedewitz, Matthew A. ;
Jones, A. Daniel ;
D'Auria, John C. ;
Barry, Cornelius S. .
NATURE COMMUNICATIONS, 2018, 9
[4]   Highly Enantioselective Catalytic Dynamic Resolution of N-Boc-2-lithiopiperidine: Synthesis of (R)-(+)-N-Boc-Pipecolic Acid, (S)-(-)-Coniine, (S)-(+)-Pelletierine, (+)β-Conhydrine, and (S)-(-)-Ropivacaine and Formal Synthesis of (-)-Lasubine II and (+)-Cermizine C [J].
Beng, Timothy K. ;
Gawley, Robert E. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (35) :12216-12217
[5]   BIOSYNTHESIS OF LYCOPODINE - PELLETIERINE AS AN OBLIGATORY INTERMEDIATE [J].
BRAEKMAN, JC ;
SPENSER, ID ;
MACLEAN, DB ;
GUPTA, RN .
CANADIAN JOURNAL OF CHEMISTRY, 1972, 50 (16) :2591-&
[6]   Improved protocol for asymmetric, intramolecular heteroatom Michael addition using organocatalysis: Enantioselective syntheses of homoproline, pelletierine, and homopipecolic acid [J].
Carlson, Erik C. ;
Rathbone, Lauren K. ;
Yang, Hua ;
Collett, Nathan D. ;
Carter, Rich G. .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (13) :5155-5158
[7]   Huperzine alkaloids: forty years of total syntheses [J].
Cheng, Bichu ;
Song, Lili ;
Chen, Fener .
NATURAL PRODUCT REPORTS, 2024, 41 (01) :59-84
[8]   THE SYNTHESIS OF CYCLOOCTATETRAENE FROM PSEUDOPELLETIERINE [J].
COPE, AC ;
OVERBERGER, CG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1947, 69 (04) :976-976
[9]   CYCLIC POLYOLEFINS .1. SYNTHESIS OF CYCLOOCTATETRAENE FROM PSEUDOPELLETIERINE [J].
COPE, AC ;
OVERBERGER, CG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1948, 70 (04) :1433-1437
[10]  
EricGershwin M., 1996, CLIN REV ALLERG IMMU, V14, P241, DOI [10.1007/BF02802216, DOI 10.1007/BF02802216]